FTC Releases Second Interim Staff Report on Prescription Drug …
Jan 14, 2025 · The Federal Trade Commission today published a second interim staff report on the prescription drug middleman industry, which focuses on pharmacy benefit managers’ …
FTC Sues Prescription Drug Middlemen for Artificially Inflating …
Sep 20, 2024 · The FTC’s administrative complaint alleges that CVS Health’s Caremark, Cigna’s ESI, and United Health Group’s Optum, and their respective GPOs—Zinc Health Services, …
Caremark Rx, Zinc Health Services, et al., In the Matter of (Insulin ...
4 days ago · Learn about the FTC's notable video game cases and what our agency is doing to keep the public safe. Latest Data Visualization. FTC Refunds to Consumers. ... Caremark Rx, …
Federal Trade Commission accuses three drug middlemen of …
Sep 21, 2024 · In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription …
Federal Trade Commission sues largest drug middlemen for
Sep 20, 2024 · The agency alleges that CVS Health’s Caremark Rx, Cigna’s Express Scripts and UnitedHealth Group’s Optum Rx and their affiliated group purchasing organizations created a …
Drug middlemen illegally drive up the cost of insulin, FTC says
Sep 20, 2024 · CVS Caremark and Optum disputed the FTC's allegations. "CVS Caremark is proud of the work we have done to make insulin more affordable for all Americans with …
CVS Caremark, Express Scripts, OptumRx markups made billions: FTC …
Jan 14, 2025 · Pharmacy benefit managers CVS Caremark, OptumRx and Express Scripts inflated costs for specialty generic drugs to treat diseases such as cancer and HIV to the tune …
UnitedHealth and CVS accuse FTC commissioners of anti-PBM …
Oct 9, 2024 · Cigna, UnitedHealth and CVS Caremark are calling Federal Trade Commission (FTC) Chair Lina Khan and two other commissioners to either recuse themselves, or be …
FTC again goes after PBMs’ business practices in new report
Jan 14, 2025 · The Federal Trade Commission has released a second report examining how pharmacy benefit managers may be inflating drug costs in the U.S., in the latest and likely last …
PBMs made billions marking up specialty drugs by more than …
Jan 14, 2025 · The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying the major industry middlemen generate …